Examining CBD use for conditions with proven therapies

What The Study Did:

Testimonials posted on a social media site were analyzed to examine whether individuals are using the cannabis-derived chemical compound cannabidiol (CBD) in an attempt to treat diagnosable conditions that have evidence-based therapies.

Authors:

John W. Ayers, Ph.D., M.A., of the University of California, San Diego, is the corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamanetworkopen.2020.20977)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:

The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

http://jamanetwork.

com/

journals/

jamanetworkopen/

fullarticle/

10.

1001/

jamanetworkopen.

2020.

20977?utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_term=

101520

About

JAMA Network Open:



JAMA Network Open

is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.